Studies on the mode of action of RC4, a new anti-cancer agent containing ethyleneimino ring. I. Effects of RC4 and allied agents on glycolysis, respiration, hexokinase and phosphatase of Ehrlich ascites tumor cells and on choline-esterase of human blood.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002286:Carcinoma, Ehrlich Tumor; D002794:Choline; D002802:Cholinesterases / Q000097:blood*; D004950:Esterases; D006019:Glycolysis; D006593:Hexokinase; D006801:Humans; D009369:Neoplasms / Q000378:metabolism*; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism*; D010770:Phosphotransferases / Q000378:metabolism*
D000970:Antineoplastic Agents; D010770:Phosphotransferases; D006593:Hexokinase; D004950:Esterases; D002802:Cholinesterases; D010744:Phosphoric Monoester Hydrolases; D002794:Choline
ANTINEOPLASTIC AGENTS/pharmacology; CHOLINESTERASE/blood; NEOPLASMS/metabolism; PHOSPHATASES/metabolism; TRANSPHOSPHORYLASES/metabolism